Physician profile
Malcolm J Stubbs
NPI 1770514333
$8,070.72
in general payments reported to CMS, 2019-2025
18 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $1,080 · 2021: $1,691 · 2022: $1,313 · 2023: $1,588 · 2024: $614 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,561 · Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,561.11 |
| Food and Beverage | $1,071.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,346.45 | 2020-2024 | Mymobility Platform |
| Alon Medical Technology | $1,952.11 | 2021-2025 | |
| Fx Shoulder Solutions, INC | $865.32 | 2019 | |
| Arthrex, INC. | $631.16 | 2023 | |
| Uoc USA INC | $460.96 | 2019 | |
| Surgentec | $447.39 | 2024 | Tilink, Ion |
| Biom'Up France Sas | $276.14 | 2020-2021 | |
| Next Science LLC | $222.75 | 2020-2025 | Blastx, Xperience |
| Stryker Corporation | $220.31 | 2022-2025 | Mako, Pangea, Variax |
| Biorez, INC. | $133.70 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $124.87 | 2025 | Iovera |
| Interventional Pain Technologies INC. | $93.36 | 2021 | |
| Smith+Nephew, INC. | $88.53 | 2022 | |
| Nextstep Arthropedix, LLC | $82.42 | 2020 | |
| Si-Bone, INC. | $47.30 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $35.97 | 2025 | Evoke |
| Ethicon US, LLC | $27.70 | 2019 | |
| Innovation Technologies INC | $14.28 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Stubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.